Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
47.60
+0.45 (0.95%)
Mar 3, 2025, 5:31 PM CET

Basilea Pharmaceutica AG Statistics

Total Valuation

SWX:BSLN has a market cap or net worth of CHF 577.38 million. The enterprise value is 568.34 million.

Market Cap 577.38M
Enterprise Value 568.34M

Important Dates

The last earnings date was Tuesday, February 18, 2025.

Earnings Date Feb 18, 2025
Ex-Dividend Date n/a

Share Statistics

SWX:BSLN has 12.13 million shares outstanding. The number of shares has increased by 14.10% in one year.

Current Share Class n/a
Shares Outstanding 12.13M
Shares Change (YoY) +14.10%
Shares Change (QoQ) +0.48%
Owned by Insiders (%) 0.27%
Owned by Institutions (%) 34.57%
Float 12.10M

Valuation Ratios

The trailing PE ratio is 8.17 and the forward PE ratio is 13.32. SWX:BSLN's PEG ratio is 0.27.

PE Ratio 8.17
Forward PE 13.32
PS Ratio 2.76
PB Ratio 7.13
P/TBV Ratio 7.16
P/FCF Ratio 7.95
P/OCF Ratio n/a
PEG Ratio 0.27
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.73, with an EV/FCF ratio of 7.82.

EV / Earnings 7.32
EV / Sales 2.73
EV / EBITDA 8.73
EV / EBIT 9.21
EV / FCF 7.82

Financial Position

The company has a current ratio of 4.85, with a Debt / Equity ratio of 1.38.

Current Ratio 4.85
Quick Ratio 3.93
Debt / Equity 1.38
Debt / EBITDA 1.71
Debt / FCF 1.54
Interest Coverage 14.20

Financial Efficiency

Return on equity (ROE) is 218.58% and return on invested capital (ROIC) is 24.78%.

Return on Equity (ROE) 218.58%
Return on Assets (ROA) 17.89%
Return on Invested Capital (ROIC) 24.78%
Return on Capital Employed (ROCE) 29.07%
Revenue Per Employee 1.27M
Profits Per Employee 473,128
Employee Count 164
Asset Turnover 0.97
Inventory Turnover 3.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +31.15% in the last 52 weeks. The beta is 0.68, so SWX:BSLN's price volatility has been lower than the market average.

Beta (5Y) 0.68
52-Week Price Change +31.15%
50-Day Moving Average 41.68
200-Day Moving Average 42.35
Relative Strength Index (RSI) 75.59
Average Volume (20 Days) 53,356

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SWX:BSLN had revenue of CHF 208.54 million and earned 77.59 million in profits. Earnings per share was 5.82.

Revenue 208.54M
Gross Profit 92.72M
Operating Income 61.70M
Pretax Income 60.26M
Net Income 77.59M
EBITDA 63.13M
EBIT 61.70M
Earnings Per Share (EPS) 5.82
Full Income Statement

Balance Sheet

The company has 120.71 million in cash and 111.67 million in debt, giving a net cash position of 9.04 million or 0.75 per share.

Cash & Cash Equivalents 120.71M
Total Debt 111.67M
Net Cash 9.04M
Net Cash Per Share 0.75
Equity (Book Value) 81.00M
Book Value Per Share 6.68
Working Capital 175.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.36 million and capital expenditures -1.71 million, giving a free cash flow of 72.65 million.

Operating Cash Flow 74.36M
Capital Expenditures -1.71M
Free Cash Flow 72.65M
FCF Per Share 5.99
Full Cash Flow Statement

Margins

Gross margin is 44.46%, with operating and profit margins of 29.59% and 37.21%.

Gross Margin 44.46%
Operating Margin 29.59%
Pretax Margin 28.90%
Profit Margin 37.21%
EBITDA Margin 30.27%
EBIT Margin 29.59%
FCF Margin 34.84%

Dividends & Yields

SWX:BSLN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.10%
Shareholder Yield -14.10%
Earnings Yield 13.44%
FCF Yield 12.58%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SWX:BSLN has an Altman Z-Score of -0.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.94
Piotroski F-Score n/a